Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Pozycja w akcjach
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Cena akcji
$20.91
Kapitalizacja rynkowa
$7.57B
Zmiana (1 dzień)
-8.26%
Zmiana (1 rok)
41.25%
Kraj
CN
Handel Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Kategoria
Healthcare
EPS dla Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
EPS na dzień June 2026 TTM: $0.43
Według najnowszych raportów finansowych i ceny akcji firmy Asymchem Laboratories (Tianjin) Co., Ltd., obecny EPS (TTM) wynosi $0.43. Na koniec roku 2024 firma miała EPS w wysokości $0.37, spadek w porównaniu do do EPS z roku 2023, który wynosił $0.88.
Historia EPS dla Asymchem Laboratories (Tianjin) Co., Ltd. od 2011 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $0.43 | -3.49% |
| 2025 | $0.45 | 22.58% |
| 2024 | $0.37 | -58.33% |
| 2023 | $0.88 | -32.36% |
| 2022 | $1.31 | 163.84% |
| 2021 | $0.50 | 46.50% |
| 2020 | $0.34 | 36.19% |
| 2019 | $0.25 | 27.52% |
| 2018 | $0.19 | 17.35% |
| 2017 | $0.17 | 16.41% |
| 2016 | $0.14 | 51.86% |
| 2015 | $0.09 | 45.36% |
| 2014 | $0.06 | 30.51% |
| 2013 | $0.05 | 28.57% |
| 2012 | $0.04 | -6.55% |
| 2011 | $0.04 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| $17.32 | 3,888.03% |
US
|
|
| $-7.98 | -1,937.44% |
US
|
|
| $-5.29 | -1,318.05% |
AU
|
|
| $13.70 | 3,054.52% |
BE
|
|
| $27.74 | 6,287.29% |
NL
|
